Mangoceuticals Inc (MGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,874 | -10,255 | -4,840 | -8,707 | -6,759 |
| Depreciation Amortization | 1,276 | 1,251 | 415 | 732 | 474 |
| Accounts payable and accrued liabilities | N/A | N/A | 341 | N/A | N/A |
| Other Working Capital | -207 | 226 | 119 | 660 | 606 |
| Other Operating Activity | 12,032 | 5,247 | 1,690 | 2,452 | 1,944 |
| Operating Cash Flow | $-4,773 | $-3,531 | $-2,275 | $-4,864 | $-3,734 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | 65 | 65 |
| Investing Cash Flow | $0 | $0 | $0 | $65 | $65 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 600 | 600 | N/A | 150 | 188 |
| Common Stock Issued | 3,337 | 2,866 | 1,135 | 1,328 | 568 |
| Other Financing Activity | 1,250 | 100 | 1,150 | 2,650 | 2,250 |
| Financing Cash Flow | $5,187 | $3,566 | $2,285 | $4,128 | $3,006 |
| Exchange Rate Effect | N/A | 8 | 8 | -10 | N/A |
| Beginning Cash Position | 59 | 59 | 59 | 739 | 739 |
| End Cash Position | 481 | 101 | 77 | 59 | 74 |
| Net Cash Flow | $415 | $42 | $18 | $-680 | $-663 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,773 | -3,531 | -2,275 | -4,864 | -3,734 |
| Free Cash Flow | -4,773 | -3,531 | -2,275 | -4,864 | -3,734 |